GaviLyte - C TM
Active substance: POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM SULFATE ANHYDROUS
POWDER, FOR SOLUTION · POLYETHYLENE GLYCOL 3350 240 g/278.26g, SODIUM CHLORIDE 5.84 g/278.26g, POTASSIUM CHLORIDE 2.98 g/278.26g, SODIUM BICARBONATE 6.72 g/278.26g, SODIUM SULFATE ANHYDROUS 22.72 g/278.26g
United StatesActive
Marketing holder: Lupin Pharmaceuticals,Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- POLYETHYLENE GLYCOL 3350 · 240 g/278.26g
- SODIUM CHLORIDE · 5.84 g/278.26g
- POTASSIUM CHLORIDE · 2.98 g/278.26g
- SODIUM BICARBONATE · 6.72 g/278.26g
- SODIUM SULFATE ANHYDROUS · 22.72 g/278.26g
Registration
- Registration number
- 43386-060
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 43386-060 · Verified 2026-10-09 · open in source